Under-30s reluctant to take Covid vaccine cite fertility and side-effect concerns

Fears over experimental' inoculation show that more needs to be done to counter harmful misinformation

• Coronavirus - latest updates
• See all our coronavirus coverage

Since the vaccine rollout began last year, the journey has been relatively smooth. The few bumps that the jab juggernaut has encountered, mostly hiccups in the supply chain, have been successfully navigated.

Yet there are now concerns about the final stages, with under-30s showing markedly more reluctance to get their first dose of the Pfizer or Moderna vaccines than older people.